MINK THERAPEUTICS INC (INKT) Institutional Ownership Changes & 13F Activity
MINK THERAPEUTICS INC (INKT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Drw Securities, Llc, Longbow Finance Sa, Geode Capital Management, Llc, Ubs Group Ag, and Northwestern Mutual Wealth Management Co.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Bank Of America Corp | Buy | +568 | — | 568 | $6.33K | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +295 | — | 295 | $3.29K | Q4 2025 | Feb 17, 2026 |
| Osaic Holdings, Inc. | Buy | +117 | — | 117 | $1.30K | Q4 2025 | Feb 17, 2026 |
| Jones Financial Companies Lllp | Buy | +1 | — | 1 | $11.00 | Q4 2025 | Feb 17, 2026 |
| Citigroup Inc | Buy | +337 | — | 337 | $3.76K | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +104 | — | 104 | $1.16K | Q4 2025 | Feb 13, 2026 |
| Wells Fargo & Company/Mn | Buy | +20 | — | 20 | $223.00 | Q4 2025 | Feb 13, 2026 |
| Pinnacle Wealth Planning Services, Inc. | Buy | +5 | — | 5 | $56.00 | Q4 2025 | Feb 13, 2026 |
| Barclays Plc | Buy | +4 | — | 4 | $45.00 | Q4 2025 | Feb 13, 2026 |
| Drw Securities, Llc | Buy | +25,677 | — | 25,677 | $286.30K | Q4 2025 | Feb 12, 2026 |
| Longbow Finance Sa | Buy | +16,667 | — | 16,667 | $185.84K | Q4 2025 | Feb 12, 2026 |
| Blackrock, Inc. | Buy | +6,203 | — | 6,203 | $69.16K | Q4 2025 | Feb 12, 2026 |
| Renaissance Technologies LLC | Sell | -4,200 | -28.8% | 10,400 | $115.96K | Q4 2025 | Feb 12, 2026 |
| Jpmorgan Chase & Co | Buy | +9 | — | 9 | $100.00 | Q4 2025 | Feb 11, 2026 |
| Bnp Paribas Financial Markets | Buy | +16 | — | 16 | $178.00 | Q4 2025 | Feb 10, 2026 |
| Geode Capital Management, Llc | Buy | +14,247 | — | 14,247 | $158.88K | Q4 2025 | Feb 09, 2026 |
| Clearstead Advisors, Llc | Buy | +14 | — | 14 | $157.00 | Q4 2025 | Feb 09, 2026 |
| Key Financial Inc | Buy | +4 | — | 4 | $45.00 | Q4 2025 | Feb 09, 2026 |
| Covestor Ltd | Buy | +131 | — | 131 | $1.00K | Q4 2025 | Feb 06, 2026 |
| Northwestern Mutual Wealth Management Co | Buy | +7,774 | — | 7,774 | $2.66M | Q4 2025 | Feb 05, 2026 |
| Ubs Group Ag | Buy | +9,548 | — | 9,548 | $106.46K | Q4 2025 | Jan 29, 2026 |
| Game Plan Financial Advisors, Llc | Buy | +16 | — | 16 | $178.00 | Q4 2025 | Jan 14, 2026 |
| Horizon Financial Services, Llc | Buy | +160 | — | 160 | $1.78K | Q4 2025 | Jan 12, 2026 |
Frequently asked questions about INKT activity
Which institutional owners are buying INKT?
Institutional owners buying INKT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in INKT activity?
"Buy" means an investor increased their reported position in INKT compared to the prior reporting period. This reflects growing exposure to MINK THERAPEUTICS INC (INKT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in INKT increasing?
Institutional interest in INKT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related INKT Institutional Insights
- INKT Overview
- INKT 13F Institutional Holders
- INKT Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- INKT Insider Trading & SEC Form 4 Activity
- INKT Articles
- Top Institutional Investor Stock Rankings